Nyxoah Annonce que l’Étude Pivot DREAM U.S. Atteint les Critères d’Évaluation Primaires
Le taux de réponse à l’indice d’apnée-hypopnée (IAH) est de 63,5 % en intention de traiter (ITT) (p=0,002).
Taux de réponse à l’indice de désaturation en oxygène (IDO) de 71,3 % en intention de traiter (ITT) (p<0,001)
Réduction médiane de l’IAH à 12 mois de 70,8%.
NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.
